This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bell, M. E. Articles by Myers, D. A. Search for Related Content PubMed PubMed Citation Articles by Bell, M. E. Articles by Myers, D. A.

Fetal Sheep Pituitary Proopiomelanocortin in Late Gestation: Effect of Bilateral Lesions of the Paraventricular Nucleus on Regional and Cellular Messenger Ribonucleic Acid Levels¹

Department of Physiology (M.E.B., T.R.M., D.A.M.), College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73190; and Department of Physiology (T.J.M.), Cornell University College of Veterinary Medicine, Ithaca, New York 14850

Address all correspondence and requests for reprints to: Dr. Dean Myers, Department of Physiology, BMSB 653, University of Oklahoma Health Sciences Center, Post Office Box 26901, Oklahoma City, Oklahoma 73190. E-mail: dean-myers{at}uokhsc.edu

Previous experiments have clearly indicated that the successful completion of ovine gestation is dependent upon fetal adrenocortical maturation and the associated preterm rise in fetal plasma cortisol. The purposes of this study were to: 1) examine pituitary POMC messenger RNA (mRNA) levels during normal fetal development; and 2) examine the effects of bilateral lesion of the fetal paraventricular nucleus (PVN) on levels and spatial distribution of pituitary POMC mRNA.

Pituitary glands were collected from intact fetal sheep of four gestational ages [100–107 days gestational age (dga), n = 8; 117–121 dga, n = 9; 126–130 dga, n = 9; 144–147 dga, n = 8]. Lesions of the PVN (PVN Lx; n = 4) or sham lesions (Sham; n = 5) were performed at 118–122 dga. Pituitary glands from PVN Lx and Sham fetuses were collected at 139–142 dga (term 147 dga). POMC mRNA levels were determined by in situ hybridization. POMC transcript levels were determined by both regional analysis (20x magnification) and analysis of individual corticotropes (400x magnification).

There was no difference among gestational age groups in superior anterior pituitary (AP) POMC mRNA levels determined by regional or cellular analysis. POMC mRNA levels were significantly greater in the inferior AP at 144–147 dga, compared with other gestational ages, using regional analysis (P = 0.003) or analysis of individual corticotropes (P < 0.01). POMC mRNA levels in the neurointermediate lobe in 126- to 130-dga fetuses were significantly greater than those in younger fetuses (P = 0.005) but not those in 144- to 147-dga fetuses.

There was no difference in POMC mRNA levels in the superior AP between PVN Lx and Sham, using regional analysis or analysis of individual corticotropes. In the inferior AP, there was a significant decrease in POMC mRNA levels in PVN Lx, compared with Sham, using both regional analysis (P < 0.01) and cellular analysis (P < 0.01). There was no difference in POMC mRNA levels in the neurointermediate lobe as the result of bilateral PVN Lx.

Our findings support that basal AP POMC mRNA levels are heterogenously distributed in the ovine fetal AP, with POMC mRNA levels in the inferior AP being significantly greater than in superior AP, by 144–147 dga. We further found that the higher POMC mRNA levels in the inferior AP reflect significantly higher corticotrope POMC transcripts and not simply a greater density of corticotropes in this AP region. The increase in POMC mRNA levels at 144–147 dga in the inferior AP seems unrelated to the onset of adrenocortical maturation (at 125–130 dga). Finally, we report that increase in corticotrope POMC transcripts during late gestation in the inferior AP requires an intact PVN.

This article has been cited by other articles:

				M. Keller-Wood, M. J. Powers, J. A. Gersting, N. Ali, and C. E. Wood Genomic analysis of neuroendocrine development of fetal brain-pituitary-adrenal axis in late gestation Physiol Genomics, February 23, 2006; 24(3): 218 - 224. [Abstract] [Full Text] [PDF]

				M. E. Bell, T. J. McDonald, and D. A. Myers Proopiomelanocortin Processing in the Anterior Pituitary of the Ovine Fetus after Lesion of the Hypothalamic Paraventricular Nucleus Endocrinology, June 1, 2005; 146(6): 2665 - 2673. [Abstract] [Full Text] [PDF]

				D. A. Myers, M. E. Bell, T. J. McDonald, and T. R. Myers Corticotropin-Releasing Factor Receptor Expression in the Pituitary of Fetal Sheep after Lesion of the Hypothalamic Paraventricular Nucleus Endocrinology, September 1, 1999; 140(9): 4292 - 4299. [Abstract] [Full Text]

				M. E. Bell, T. R. Myers, and D. A. Myers Expression of Proopiomelanocortin and Prohormone Convertase-1 and -2 in the Late Gestation Fetal Sheep Pituitary Endocrinology, December 1, 1998; 139(12): 5135 - 5143. [Abstract] [Full Text] [PDF]